|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
10865 Road To The Cure, Ste 150, San Diego, CA - California 92121, US
|
|
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other medical conditions. Capricor's lead candidate, CAP-1002, is a cardiac cell therapy that is currently being evaluated for the treatment of heart disease associated with Duchenne muscular dystrophy and myocardial infarction (heart attack). In addition, the Company is conducting research and development on its exosomes (CAP-2003) platform technology for cardiac diseases and other potential indications.
|
Capricor Therapeutics, Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
66.67%
|
The widely used Capricor Therapeutics, Inc. email format is {f}{last} (e.g. [email protected]) with 66.67% adoption across the company.
To contact Capricor Therapeutics, Inc. customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.